United Therapeutics Corporation Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
United Therapeutics (UTHR) Tops Q1 EPS by 55c, Revenues Beat
May 5, 2021 6:05 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.49, $0.55 better than the analyst estimate of $2.94. Revenue for the quarter came in at $379.1 million versus the consensus estimate of $368.95 million.
"2021 is already a historic year for United Therapeutics, with the recent FDA approval and launch... More
